Today, in a letter to the Editor of The Times, Breast Cancer Now and other charities including Prostate Cancer UK, Alzheimer’s Society and MS Society, raise concerns about the devastating impact the proposed cost-cap could have on millions of patients.
The proposal would allow NHS England and NICE to delay access to new treatments that cost over £20 million per year – despite having already been approved for use. The cost-cap could see one in five new treatments delayed.
The charities call on NICE and NHS England to reconsider the proposal and work with their partners to give patients the best possible chance of accessing the drugs they need.
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:
“The budget impact threshold proposal could significantly delay access to a number of effective treatments for a variety of medical conditions.
“It is already proving extremely difficult to get breast cancer drugs approved by NICE. We are therefore very concerned that this proposal could be a significant, additional barrier in getting new and effective treatments to those patients who so desperately need them, including patients living with incurable breast cancer who are relying on access to new drugs to give them additional, quality time with their loved ones.
“We therefore urge NICE and NHS England to work with partners to find a solution that does not delay access to vital drugs, to avoid what could possibly result in a devastating impact on patients.”
Read the article on The Times website - full article behind paywall.